New experimental studies by numerous research groups, including the Max Planck Institute for Evolutionary Biology (MPI-EB) in Plön and Kiel University (CAU), suggest that evolutionary medicine could ...

SAN DIEGO — In tough-to-treat chronic inflammatory bowel disease (IBD), a precision-medicine strategy based on patients’ molecular profiles showed efficacy in guiding anti–tumor necrosis factor ...

Researchers at the Icahn School of Medicine at Mount Sinai have found that exposure to per- and polyfluoroalkyl substances ...

A research team at McMaster University has developed a targeted approach to treating inflammatory bowel disease (IBD) using ...

The first-ever global guidelines for pregnancy and inflammatory bowel disease (IBD) recommend continuing biologics and low-risk medications through pregnancy and lactation in women with IBD, ...

The MarketWatch News Department was not involved in the creation of this content. Internationally recognized leaders in inflammatory bowel disease bring deep expertise spanning ulcerative colitis, ...

The great news is that today, there are more effective and diverse treatment options for IBD than ever before, thanks to recent advances in medications and therapies. With so many choices available, ...

Carlsbad, CA, May 01, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a clinical-stage biopharmaceutical company focused on developing and ...

Precision medicine could transform the way Crohn’s disease and ulcerative colitis are treated - shifting the focus from symptom control to targeted, data-driven therapies designed for durable ...